SeaStar Medical Holding Corporation Share Price
ICUSeaStar Medical Holding Corporation Stock Performance
Open $3.84 | Prev. Close $3.86 | Circuit Range N/A |
Day Range $3.75 - $3.86 | Year Range $0.22 - $5.31 | Volume 1,009 |
Average Traded $3.81 |
SeaStar Medical Holding Corporation Share Price Chart
About SeaStar Medical Holding Corporation
SeaStar Medical Holding Corporation, a commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.
SeaStar Medical Holding Corporation Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
21-Jul-26 | $3.84 | $3.84 | +0.00% |
21-Jul-26 | $3.84 | $3.84 | -0.52% |
20-Jul-26 | $3.87 | $3.86 | -4.69% |
17-Jul-26 | $4.23 | $4.05 | -5.15% |
16-Jul-26 | $4.30 | $4.27 | -12.32% |
14-Jul-26 | $4.60 | $4.87 | +1.46% |
13-Jul-26 | $4.88 | $4.80 | -2.24% |